Legend Biotech Corporation (FRA:9LB)

Legend Biotech Revenue

Legend Biotech had revenue of $387.50M USD in the quarter ending June 30, 2026, with 51.90% growth. This brings the company's total for the last twelve months to $1.27B, up 59.54% year-over-year. In the year 2025, Legend Biotech had annual revenue of $1.03B with 64.02% growth.

• Revenue (ttm): $1.27B
• Revenue Growth: +59.54%
• P/S Ratio: 3.00
• Revenue / Employee: $397.26K
• Employees: 3,200
• Market Cap: 3.33B EUR

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Segment

By Segment

Chart

• Collaboration 944.80M 91.8%
• License 83.80M 8.1%
• Other Service 300.00K 0.0%

By Geography

Chart

• United States of America 803.60M 78.1%
• Europe 198.70M 19.3%
• China 26.60M 2.6%

Fiscal year ended Dec 31, 2025 See the full Legend Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.03B	401.60M	64.02%
Dec 31, 2024	627.30M	342.20M	120.03%
Dec 31, 2023	285.10M	168.10M	143.66%
Dec 31, 2022	117.01M	48.18M	70.00%
Dec 31, 2021	68.83M	-6.17M	-8.23%
Dec 31, 2020	75.00M	15.02M	25.04%
Dec 31, 2019	59.98M	10.85M	22.08%
Dec 31, 2018	49.13M	25.54M	108.24%
Dec 31, 2017	23.59M	-	-

Data Source: Fiscal.ai Last updated: Jun 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error